Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SY-4835 in advanced solid tumors
NCT05291182Phase 1Unknown
- Sponsor
- Shouyao Holdings
- Start
- Jun 2021
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Phase 1, open-label trial of SY-4835 in solid tumor (advanced stage), sponsored by Shouyao Holdings. Status: unknown.
02
Drugs
SY-4835
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05291182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05291182.